Innova Captab Limited has announced its earnings call to discuss the operational and financial performance for Q4 and FY26. The company has scheduled a virtual meeting with analysts and institutional investors to review the audited financial results for the quarter and financial year ended March 31, 2026.

Earnings Call Details

The pharmaceutical company has provided comprehensive details for the upcoming earnings call through its regulatory filing dated April 30, 2026.

Regulatory Compliance

The announcement has been made pursuant to Regulation 30 read with Schedule III Part A – Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally notified both stock exchanges about this scheduled interaction.

Stock Exchange Notifications:

• BSE Limited (Symbol: INNOVACAP, Scrip Code: 544067)
• National Stock Exchange of India Limited (Symbol: INNOVACAP)

Company Representatives

The earnings call will feature key leadership members who will present and discuss the company's financial performance:

• Mr. Vinay Lohariwala – Managing Director
• Mr. Lokesh Bhasin – Chief Financial Officer

Access Information

The company has provided multiple access options for participants, including primary numbers and international toll-free numbers for various regions.

Event Coordination

Strategic Growth Advisors Pvt. Ltd. is coordinating the earnings call, with Ms. Shaily Patwa and Mr. Shrikant Sangani serving as the primary contacts. The company has requested participants to pre-register for the call and noted that changes may occur due to exigencies on the part of participants or the company.

The filing was signed by Neeharika Shukla, Company Secretary and Compliance Officer, and submitted to maintain transparency with stakeholders regarding the scheduled investor interaction.

Innova Captab Limited has received a reaffirmation of its credit ratings from CARE Ratings Limited, maintaining its strong financial standing in the market. The rating agency conducted a comprehensive review based on the company's operational and financial performance for FY25 (Audited) and 9MFY26 (Unaudited), resulting in positive outcomes across all facility categories.

Credit Rating Details

CARE Ratings has reaffirmed Innova Captab's credit ratings with notable enhancements in facility amounts. The rating review, completed on April 14, 2026, reflects the company's continued financial stability and growth trajectory.

The long term bank facilities rating of CARE A; Positive indicates adequate degree of safety regarding timely servicing of financial obligations, with the positive outlook suggesting potential for rating upgrade. The short term facilities maintain the CARE A1 rating, reflecting strong degree of safety for timely payment of financial obligations.

Facility Structure and Banking Partners

The enhanced bank facilities demonstrate Innova Captab's expanded financial capacity and strong banking relationships. The long term facilities totaling ₹426.72 crore comprise term loans of ₹243.72 crore and fund-based limits of ₹183.00 crore.

Term Loan Details

Fund-Based Facilities

The company maintains diversified banking relationships with multiple leading financial institutions:

• State Bank of India: ₹115.00 crore (Cash Credit ₹65.00 crore, E-VFS ₹50.00 crore)
• Yes Bank Ltd.: ₹48.00 crore (Cash Credit)
• HDFC Bank Ltd.: ₹20.00 crore (Cash Credit)

Regulatory Compliance

Innova Captab promptly informed both BSE Limited and National Stock Exchange of India Limited about the rating reaffirmation on April 14, 2026. The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company trades on both exchanges under the symbol INNOVACAP, with BSE Scrip Code 544067. Company Secretary and Compliance Officer Neeharika Shukla signed the regulatory filing, ensuring full compliance with listing obligations.

Rating Methodology and Outlook

CARE Ratings conducted the review based on recent developments including operational and financial performance metrics. The rating agency reserves the right to undertake surveillance and review of the rating from time to time, with at least one such review annually. The ratings reflect opinions on the likelihood of timely payment of obligations and do not constitute recommendations for sanctioning or recalling bank facilities.